Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9915649
SERIAL NO

15097218

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BIOMARIN PHARMACEUTICAL INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beitel, Jim R Novato, US 11 112
Brown, Jillian R Poway, US 20 238
Crawford, Brett E Poway, US 23 252
Glass, Charles A Novato, US 26 262
Jackman, Robin M San Diego, US 18 118

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 13, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 13, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00